Dental Care Clinics in West Bloomfield, MI Accepting Medicare
43 Dental Care Clinics found. Showing 41 - 43
 Prosthodontic & Implant Consultants Pc Dentist Medicare: Not Enrolled in Medicare Practice Location: 6177 Orchard Lake Road, Suite #120, West Bloomfield, MI 48322 Phone: 248-855-6655 Fax: 248-855-0803 |
Royal Dental Center Pllc Clinic/Center - Dental Medicare: Not Enrolled in Medicare Practice Location: 4819 Haggerty Rd, West Bloomfield, MI 48323 Phone: 248-863-9109 |
Orchard Maple Family Dental, Pllc Dentist - General Practice Medicare: Not Enrolled in Medicare Practice Location: 6280 Orchard Lake Rd, West Bloomfield, MI 48322 Phone: 248-851-2876 Fax: 248-851-1669 |
News Archive
Safeway raises funds to support neuromuscular disease medical research and therapies
Safeway Inc. announced today it has raised a record $10.2 million to support medical research and services for the millions of people living with neuromuscular diseases. The funds were raised during Safeway's annual Muscular Dystrophy Association (MDA) campaign, a five-week endeavor to highlight the need to find cures and treatments for muscular dystrophy and related diseases, and presented during the Jerry Lewis MDA Telethon in Las Vegas Labor Day weekend.
Millennium submits two VELCADE sNDAs to FDA
Millennium: The Takeda Oncology Company with its parent company Takeda Pharmaceutical Company Limited today announced that it has submitted two supplemental new drug applications (sNDAs) for VELCADE® (bortezomib) for Injection to the U.S. Food and Drug Administration. The first application seeks to add a subcutaneous route of administration for VELCADE. The second application is for the use of VELCADE in combination with rituximab in patients with relapsed follicular non-Hodgkin lymphoma (NHL).
EPO issues grant for a patent in Kreutzer-Limmer III patent series
Alnylam Pharmaceuticals, Inc., a leading RNAi therapeutics company, announced today that the European Patent Office (EPO) has issued a notification of intent to grant for a patent in the Kreutzer-Limmer III patent series (EP Application No 02702247.4). This patent series stems from the pioneering RNAi research performed by scientists at Ribopharma AG, which was acquired by Alnylam in 2003.
Elimination of sugar-sweetened beverages from school menus shown not to affect total consumption by adolescents
With childhood obesity increasing, school administrators and public health officials are reducing availability of sugar-sweetened beverages (SSB) in schools.
› Verified 7 days ago